MedPath

Can Vitamin C reduces COVID-19 symptoms

Phase 4
Conditions
Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Registration Number
CTRI/2020/10/028695
Lead Sponsor
il
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Age more than 18years ,

COVID-19 positive(RT-PCR)

either sex

Symptomatic patient(fever, cough and breathing difficulty)

Exclusion Criteria

1.History of allergy to vitamin C

2.Pregnant females or breastfeeding mothers

3.Critical ill patient who are intubation and on mechanical ventilation

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvement in illness can be assessed reduction in the grading (mild,moderate sever) of symptoms after l administration of vitamin C (5oomg, twice a day) in COVID19 patients. <br/ ><br>Timepoint: maximum time is 14 days
Secondary Outcome Measures
NameTimeMethod
2.To assess the effect on duration of illness by oral administration of vitamin C (500mg, twice a day) in COVID-19 patients <br/ ><br> <br/ ><br> <br/ ><br>Timepoint: maximum time is 14 days
© Copyright 2025. All Rights Reserved by MedPath